By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Popular Smoking Cessation Drug Increases Adverse Cardiac Risk
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Popular Smoking Cessation Drug Increases Adverse Cardiac Risk
Business

Popular Smoking Cessation Drug Increases Adverse Cardiac Risk

MichaelDouglas1
MichaelDouglas1
Share
0 Min Read
SHARE

First, and almost immediately out of the box, it was the concern for serious mental health effects.[1] Now, somewhat controversial smoking cessation drug varenicline (Chantix) First, and almost immediately out of the box, it was the concern for serious mental health effects.[1] Now, somewhat controversial smoking cessation drug varenicline (Chantix) is the target of the FDA with respect to the increased risk of heart disease for those taking it. Of course, the FDA rates this as only a “small” risk as it “continues to evaluate its safety”.

The new warning comes from a 700-person trial in which patients who took Chantix (varenicline) over 12 weeks were more likely to experience an adverse heart event after one year than those who received a placebo. All of the patients had already been diagnosed with heart disease. For both groups, the heart attack risk was still small: 7 out of 353 patients taking Chantix had a nonfatal heart attack, versus 3 out of 350 who took a placebo.

  1. Pfizer, the drug’s manufacturer was also the target of claims of an increased risk of suicidal ideation for those taking the drug — to a lesser extent, night terrors and delirium.

Related posts:

  1. NEJM Study: Two Popular Blood Thinners Effective for Stroke Risk Reduction in Appropriate Candidates No April Fool’s Joke here. A new study shows combining…
  2. Saturday Briefs in Cardiac Medical News Vanderbilt University (my undergrad alma mater) has announced that it…
  3. NEJM: Intensive Antidiabetic Treatment with Respect to Cardiac Risk Factors in Diabetics Harmful Diabetes mellitus, type 2 is an epidemic problem in the…

 

TAGGED:chantixhealthcare businesssmoking
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

how to improve REM sleep
Unlock Better Sleep: How to Improve REM Sleep Naturally
Wellness
October 30, 2025
uv protection in winter
Winter Sun Safety: Why UV Protection Matters Year-Round
Health
October 29, 2025
Nurse Scheduling Software
Evaluating 7 Best Nurse Scheduling Software
Nursing Technology
October 28, 2025
contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025

You Might also Like

Healthcare Technology Showcase and Learning Center in Washington DC

April 1, 2011
Medical Marketing, Physician Marketing, Online Marketing
Business

5 Ways to Market Yourself as a Medical Expert

February 5, 2014

New York’s Fully Integrated Duals Advantage Program: An Overview

June 13, 2014

Medicare Benefits Good Step Towards Prevention

June 23, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?